MedTrace Logo

Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo

NCT01890538 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2014-05-05

No results posted yet for this study

Summary

This study aims to investigate efficacy of two different intravenous drugs (dimenhydrinate and piracetam) in the symptomatic management of peripheral vertigo.

The patients will be randomized in two groups according to symptomatic treatment modalities: Dimenhydrinate (100 mg) and piracetam (2 g) will be given in 100 cc normal saline in 30 minutes. Each patient will be asked if her/his vertigo symptoms resolved or not, according to a numeric rating scale (0=no vertigo, 10=worst possible vertigo). The patient will be rate the intensity of symptoms in the following times:

* Numeric rating scale (1 to 10): Admission
* Numeric rating scale (1 to 10): After the study drug (No ambulation)\*
* Numeric rating scale (1 to 10): After the study drug (Ambulation)\*

* Ambulation refers to head movements or walking in the room, if applicable.

Conditions

  • Peripheral Vertigo

Interventions

DRUG

Administration of 100 mg dimenhydrinate intravenous

DRUG

2 g piracetam intravenous

Sponsors & Collaborators

  • Kocaeli University

    lead OTHER

Principal Investigators

  • Nurettin Özgür Doğan, M.D., Assistant Professor · Kocaeli University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01890538 on ClinicalTrials.gov